Articles

Many energy consumers, and even analysts and policymakers, confront and frame energy and climate risks in a moral vacuum, rarely incorporating broader social justice concerns. Here, to remedy this gap, we investigate how concepts from justice and ethics can inform energy decision-making by reframing five energy problems — nuclear waste, involuntary resettlement, energy pollution, energy poverty and climate change — as pressing justice concerns.

The authors analyze and contrast how China and India mobilized financial resources to build domestic technological innovation systems in wind energy.

Despite widespread adoption of genetically modified crops in many countries, heated controversies about their advantages and disadvantages continue. Especially for developing countries, there are concerns that genetically modified crops fail to benefit smallholder farmers and contribute to social and economic hardship. Many economic studies contradict this view, but most of them look at short-term impacts only, so that uncertainty about longer-term effects prevails. The authors address this shortcoming by analyzing economic impacts and impact dynamics of Bt cotton in India.

Recent national trends in investments in global energy research, development, and demonstration (RD&D) are inconsistent around the world. Public RD&D investments in energy are the metric most commonly used in international comparative assessments of energy-technology innovation, and the metric employed in this article. Overall, the data indicate that International Energy Agency (IEA) member country government investments have been volatile: they peaked in the late 1970s, declined during the subsequent two decades, bottomed out in 1997, and then began to gradually grow again during the 2000s.

"Without energy, there is no economy. Without climate, there is no environment. Without economy and environment, there is no material well-being, no civil society, no personal or national security. The overriding problem associated with these realities, of course, is that the world has long been getting most of the energy its economies need from fossil fuels whose emissions are imperiling the climate that its environment needs."

"...it is a mistake to see high prices as a proxy for actual hunger. Most of the world's hungry citizens do not get their food from the world market, and most who rely on the world market are not poor or vulnerable to hunger."

"Efforts to introduce novel agricultural crops or foods are welcomed and supported by some politically important groups in the developing world, ignored by others, and at times opposed by a significant few. When considering the political actors on the landscape most likely to take active positions either for or against novel foods, there is little or no evidence of political resistance to any of the biofortified foods developed thus far using conventional crop-breeding techniques, yet resistance to GMO crops has been widespread for much of the past decade. Which actors on the landscape are opposing GMOs, how powerful are they, and will their opposition weaken if the current generation of GMO crops carrying improved agronomic traits is followed by a second generation of GMOs carrying improved nutrient traits?"

Energy Policy article assessing the efficiency of coal-based power plants and its role in the performance of India's power sector.

"This introductory essay explains how this new technology is being driven by the actors (multinational corporations), markets (large global markets) and rules (intellectual property) of globalisation."

Sustaining the bioeconomy will require the adoption of a governance regime for biotechnology that helps bring a large number of developing countries into the global trading system. Failure to do so will create a "genetic divide" among countries and likely will intensify public opposition to biotechnology that will be fueled by presumptions about possible market dislocation and apparent technological disparities among nations. 3 A global governance system will require improvements in market access, development of technological capabilities, access to technology, a favorable regulatory environment for biotechnology, and management of risks and benefits associated with its use.